Bill to Improve Lives for 46 Million People, Including 300,000 Children with Arthritis ATLANTA, Sept. 30 /PRNewswire-USNewswire/ -- The Arthritis Foundation applauds the U.S. House of Representatives for passing the Arthritis Prevention, Control and Cure Act (H.R. 1210/S.984), the first comprehensive, bipartisan arthritis legislation in more than 30 years. Bill sponsor U.S. Rep Anna Eshoo (D ...

An experimental pain reliever from Pfizer Inc. significantly reduces joint pain in people with knee arthritis, according to research published Wednesday in the New England Journal of Medicine. But further studies on the drug, tanezumab, have been suspended at the request of the Food and Drug Administration .

An experimental drug that inhibits nerve growth factor on patients with arthritic knees has yielded an unexpected finding. In some patients, the drug blunted joint pain so powerfully they never felt the warning signs or twinges that they were overdoing it -- and suffered joint destruction. Arthritis - Health - Pain management - Pain - Conditions and Diseases

An experimental pain reliever from Pfizer Inc. significantly reduces joint pain in people with knee arthritis, according to research published Wednesday in the New England Journal of Medicine. But further studies on the drug, tanezumab, have been suspended at the request of the Food and Drug Administration .

Arthritis New Zealand welcomes PHARMAC’s announcement that a second biologic option for patients in New Zealand with severe Psoriatic Arthritis (PA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Juvenile Idiopathic Arthritis (JIA) will be ...